December 4, 2018
Takeda Pharmaceutical said on December 3 that it is borrowing US$3.7 billion from the Japan Bank for International Cooperation (JBIC) to finance a portion of the funds necessary for its planned acquisition of London-listed Shire and reduce its 364-day bridge...read more